Effect of Ayurveda oral medicine as an add-on therapy in lung cancer

Phase 2

• Conditions: Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

• Registration Number: CTRI/2023/07/055417
• Lead Sponsor: ALL INDIA INSTITUTE OF AYURVEDA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients of histologically proven lung malignancy (NSCLC of any subtype), willing to participate in the study

2.Patients with ECOG PS 0-III

3.Patients suffering from non-small cell lung cancer- Stage I to IV B and treatment naïve at the time of screening

4.Age- 18-75 years of age

5.Gender- both male and female (non-pregnant, non-lactating)

6.Patients with no diagnosis of cancer within the past one year

Exclusion Criteria

- Patients not willing to take part in the study

- Unable to take oral medications especially in the form of powder.

- Patients of ECOG PS IV, V

- Patients with active peptic ulcer, dyspepsia, or bleeding per rectum

- Significant cardiovascular disease, such as myocardial infarction, or cerebrovascular accident within 3 months prior to randomization, unstable arrhythmias, or unstable angina.

-Inability to comply with other requirements of the protocol

Study & Design

• Study Type: Interventional
• Study Design: Not specified